Combining sodium chloride nanoparticle osmolarity spikes with irinotecan chemoth...
연구 요약
Combining sodium chloride nanoparticle osmolarity spikes with irinotecan chemotherapy to amplify oxidative stress in the treatment of colorectal cancer.
Colloids and surfaces. B, Biointerfaces 학술지에 발표된 이 연구는 Shrestha A, Karmacharya P, Shrestha S 외 연구팀이 수행하였습니다.
이 연구는 'Combining sodium chloride nanoparticle osmolarity spikes with irinotecan chemotherapy to amplify oxidative stress in the treatment of colorectal cancer.'에 대한 과학적 분석을 제공합니다.
핵심 내용
Sodium chloride nanoparticles (SCNPs) have potential utility in anticancer treatment. When these nanoparticles enter a cell through endocytosis and disrupt cellular homeostasis, an osmotic spike is triggered inside the cell. This causes the generation of reactive oxygen species (ROS), ultimately leading to tumor cell death. We developed SCNPs and coated them with PLGA to create SC@PLGA-NPs. These were then encapsulated in lipids to produce SC@PLGA-LPs. We then incorporated irinotecan (CPT-11), resulting in the creation of SC@PLGA/CPT-11-LPs for use in the treatment of colorectal cancer. The in vitro data confirmed the successful encapsulation and release of SCNPs. This resulted in increased osmotic pressure and ROS generation. The addition of CPT-11 to SCNPs further increased ROS production. Finally, these effects, combined with the topoisomerase I inhibitory mechanism of CPT-11, resulted in the apoptosis of HT-29 cells. Intratumoral injection of SC@PLGA/CPT-11-LPs into an HT-29 xenograft mouse model provided in vivo confirmation that this is a reliable and effective method for the delivery of NPs and drugs.
일반인을 위한 해석
구체적인 실천 사항은 담당 의사 또는 약사와 상담하시기 바랍니다.
실천 사항
- 현재 복용 중인 약물이나 영양제에 대해 궁금한 점이 있다면 담당 의사 또는 약사와 상담하시기 바랍니다
- 약물이나 영양제의 용법·용량을 임의로 변경하지 마세요
- 이상 반응이 나타나면 즉시 전문가에게 문의하세요
의사/약사의 전문적 판단을 대체하지 않습니다 (PMID: 41297221)
이 연구와 관련된 약물을 복용 중인가요?
상호작용 체크하러 가기이 정보는 의학 논문의 요약이며, 의사/약사의 전문적 판단을 대체하지 않습니다.